Research Roundup

smart light bulb on orange background
Debbie Rigby rounds up the latest in research news Update on colchicine, 2017 Colchicine is currently approved for the treatment of gout. Studies indicate that it may be beneficial in a variety of other conditions, including other rheumatic diseases.  Colchicine’s anti-inflammatory effects hold promise for prevention/management of cardiovascular conditions, including acute coronary syndromes. Rheumatology 2018;57:i4-i11.

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Letter to the editor: Upschedule is about protecting patients
Next Women with Type 2 diabetes lose CVD protection